课题基金 / 基金详情

筋ジストロフィーに対するアンチセンスDNAによる化学的治療法の開発

筋ジストロフィーに対するアンチセンスDNAによる化学的治療法の開発
开发使用反义 DNA 治疗肌营养不良症的化学疗法
批准号:
08670744
负责人:
TSUKAHARA Toshifumi
金额:
$1.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

TSUKAHARA Toshifumi的其他基金

相似基金

相关文献

中文摘要
翻译
在本研究中,我们对反义寡核苷酸治疗Duchenne肌营养不良症进行了基础性研究。首先,我们建立了C2细胞向肌管诱导分化的实验系统,通过加入寡脱氧核苷酸来评估dystrophin基因的外显子跳跃。通过剪接,我们获得了共识序列的反义S-寡核苷酸。C2细胞在向肌管分化过程中用反义S寡核苷酸处理3d。对dystrophin基因的表达及剪接产物进行分析。加入5‘-和3’-剪接位点的反义S寡核苷酸后,正常剪接产物外显子22-23-24的表达显著降低,并出现外显子22-24条带。为了研究反义寡核苷酸对Ddystrophin基因外显子23的强迫跳跃作用,我们克隆了编码内含子22到内含子23的Dystrophin微基因,构建了哺乳动物正、反义RNA表达载体。将两种载体分别导入C2成肌细胞,G418筛选细胞。稳定的转化子被诱导分化为肌管,RT-PCR分析了dystrophin基因的表达。不幸的是,所有转化子的外显子22 24的表达没有显著变化。另一方面,5‘和3’剪接位点的反义寡核苷酸强制外显子跳跃的结果,提高了dystrophin基因外显子和内含子连接序列的重要性。因此,我们与Kyowa Hakko Kogyo株式会社东京研究实验室的Anazawa博士和Shinkai博士合作,研究了人类dystrophin基因第46号外显子和52号至55号外显子的序列。这些数据是应用人类化疗所必需的。
英文摘要
In this study, we did fundamental studies to develop the chemo-therapeuic treatment with antisense oligodeoxynucleotides against Duchenne muscular dystrophy. First, we developed expermental system using C2 cells which can be induced differentiation to myotube, to evaluate exon-skip of dystrophin gene by the addition of oligodeoxynucleotides. We made antisense S-oligodeoxynucleotides of consensus sequences on RNA splicing. C2 cells were treated with antisense S-oligodeoxynucleotides during the differentiation to myotube for 3 days. The expression and the spliced products of dystrophin gene were analyzed. By the addition of antisense S-oligodeoxynucleotides of5'-and 3'-splice sites, the expression of exons 22+23+24, the normal splicing product, were dramatically reduced and the band of exons 22+24 appeared. This result demonstrated that antisense oligodeoxynucleotides made forced exon-skip of exon 23 in dystrophin gene.To investigate the effect of longer antisense nucleotides, we cloned dystrophin mini-gene which encodes intron 22 to intron 23, and made mammalian expression constructs for sense and antisense RNAs. Both plasmids were transfected to C2 myoblasts and then cells were selected with G418. Stable transformants were induced differentiation to myotube and the expressed dystrophin gene were analyzed by RT-PCR.Unfortunately, there was no significant change in the expression of exons 22+24 in all transformants.On the other hand, our result of the forced exon-skip by antisense oligodeoxynucleotides of 5'-and 3'-splice sites, raise the importance of junctional sequences of exons and introns of dystrophin gene. Therefore, we investigated juntional sequences of exon 46 and exons 52 to 55 of human dystrophin gene in cooperation with Drs. Anazawa and Shinkai, Tokyo Research Laboratories of Kyowa Hakko Kogyo, Co., Ltd.These data are necessary to apply human chemotherapy.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
T.Kobayashi: "Identification of an ICE-like activity which increased by the treatment of P19EC cells with retinoic acid as protasome." J.Biochem.120. 699-70 (1996)
T.Kobayashi:“鉴定出通过用视黄酸作为蛋白酶体处理 P19EC 细胞而增加的 ICE 样活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Kobayashi, et al.: "Identification of an ICE-like activity which treatment of P19 EC cells increased by the with retinoic acid as proteasome." J.Biochem.120. 699-704 (1996)
T.Kobayashi 等人:“鉴定出一种 ICE 样活性,用视黄酸作为蛋白酶体处理 P19 EC 细胞可增加这种活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Fujita: "Involvement of Sonic hedgehog in the cell growth of LK-2cells,human Jung squamous carcinoma cells" Biochm Biophys Res Commun. 238. 658-664 (1997)
E.Fujita:“Sonic Hedgehog 参与 LK-2 细胞(人 Jung 鳞状癌细胞)的细胞生长”Biochm Biophys Res Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Mukasa, et al.: "Wortmannin enhances CPP32-like activity during neuronal differentiation of P19 embryonal carcinoma cells induced by retinoic acid." Biochem.Biphys.Res.Commun. 232. 192-197 (1997)
T.Mukasa 等人:“在视黄酸诱导的 P19 胚胎癌细胞的神经元分化过程中,渥曼青霉素可增强 CPP32 样活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Development of genetic code restoration by using artificial RNA editing
    Improvement of DNA chip system with probe-on-carriers for practical uses
    Development of the searching method for SNPs in responsible genes for muscular diseases using the DNA microarray
    • 批准号:
      12470532
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.09万
    • 财政年份:
      2000
    • 负责人:
      TSUKAHARA Toshifumi
    • 依托单位:
    Function of the interacting protein of SMN, the product of the spinal muscular atrophy gene, and neural specific splicing.
    • 批准号:
      10670619
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      TSUKAHARA Toshifumi
    • 依托单位:
    国内基金
    海外基金
    Dystrophin糖蛋白复合物负向调控突触后GABAA受体招募的机制研究
    • 批准号:
      32371014
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      童夏静
    • 依托单位:
    LncRNA-DACH1通过作用于抗肌萎缩蛋白(Dystrophin)调节钠通道和室性心律失常
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      55万元
    • 批准年份:
      2020
    • 负责人:
      潘振伟
    • 依托单位:
    LncRNA-DACH1通过作用于抗肌萎缩蛋白(Dystrophin)调节钠通道和室性心律失常
    • 批准号:
      82070344
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2020
    • 负责人:
      潘振伟
    • 依托单位:
    CRISPR-Cas系统介导的dystrophin基因转录激活研究
    • 批准号:
      81801248
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2018
    • 负责人:
      王丹妮
    • 依托单位: